NMPA Approval

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

Approval Number

国药准字H20249466

Company南京正大天晴制药有限公司

Registration Date

December 1, 2024

Drug Information

Generic Name

达格列净二甲双胍缓释片(Ⅰ)

Dosage Form

片剂

Strength

达格列净10mg（以C₂₁H₂₅ClO₆计）和盐酸二甲双胍1000mg

Drug Type

化学药品

Registration Date

December 1, 2024

Company Information

Applicant Company

Company Name南京正大天晴制药有限公司

Company Address

南京经济技术开发区惠欧路9号

Manufacturing Company

Company Name南京正大天晴制药有限公司

Company Address

南京经济技术开发区惠欧路9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

达格列净二甲双胍缓释片(Ⅰ) - NMPA 批准文号 | MedPath